Downregulation of OPCML is associated with activation of AKT signaling and aggressive phenotypes in glioblastoma cells
<i>OPCML</i> marks a neuron-leaning, less aggressive state and is associated with the regulation of PI3K-AKT-mTOR signaling in GBM. Loss of <i>OPCML</i> aligns with proliferative programs and a GBM-specific immune pattern. These data nominate <i>OPCML</i> as a prognostic marker and a surface-level modulator that could be leveraged alongside RTK/PI3K axis inhibitors in GBM.
Authors
- Y. Liu
- Zhuang Liu (ORCID: https://orcid.org/0000-0002-1629-1039)
- Wenrui Wu (ORCID: https://orcid.org/0000-0001-7245-4659)
- Chunhua Xu
- Bilin Lin
- Wu Zhou
Institutions
- Jiangxi University of Traditional Chinese Medicine (CN)
- Fujian Medical University (CN)
- Nanchang University (CN)
- First Affiliated Hospital of Jiangxi Medical College (CN)
- Jiangxi Provincial People's Hospital (CN)
- Second Affiliated Hospital of Nanchang University (CN)
- Hubei University of Arts and Science (CN)
- Jiangxi Chest Hospital (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
- Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine (CN)
- First Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-01-05
- DOI
- https://doi.org/10.3389/fonc.2025.1710073
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00